Skip to content

Author

Martín Lobo

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Current Evidence on the Lipid-Lowering Efficacy and Safety of Oral PCSK9 Inhibitors: A Systematic Review and Meta-analysis

Background: Inhibition of the proprotein convertase subtilisin/kexin type 9 (PCSK9) is a well-established therapeutic strategy for significantly reducing low-density lipoprotein cholesterol (LDL-C) levels. In recent years, new oral PCSK9 inhibitors have been developed, providing emerging evidence regarding their lipid-...

W. Masson, Martín Lobo, G. Giunta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.